A cocktail of the blood of three Singaporeans brought the president of the United States to his feet

During the treatment for the coronavirus of the president of the United States, Donald Trump, an experimental drug was used, created from the blood of three Singaporeans who had already suffered from the disease.

It is reported in the Singapore edition of The Straits Times.

According to the Trump administration, the president was treated with an experimental development of REGN-COV2, which was created by the biotech company Regeneron. Commissioned by the US National Center for Infectious Diseases (NCID), Regeneron selected 20 Singaporeans who had already had coronavirus, and then reduced their number to three.

“REGN-COV2 is a combination or ‘cocktail’ of two antibodies, which are proteins. They bind to the virus and prevent it from invading human cells,” says the message.

So, from the blood of people who have had coronavirus, a drug was obtained that hinders the mutation of the coronavirus and can resist the antibodies that the virus produces in response, attacking its different parts.

We will remember, in the blood of the President of the United States, Donald Trump, who last week was diagnosed with the COVID-19 coronavirus, antibodies were found. “He has had no temperature for more than four days, he has no symptoms for more than a day,” says a report released by Trump’s spokesman.

As reported by “Strana”, the President of the United States, Donald Trump, spent three days in the clinic, where he underwent treatment for the coronavirus infection, but has already returned safely to the White House and began his duties.